Description

Riboxin-Darnitsa (inosine) ampoules 20 mg/ml 5 ml. №10

Ingredients:

Each ampoule contains 20 mg/ml of inosine.

Dosage:

The usual dose is 1-2 ampoules per day, administered intravenously or intramuscularly.

Indications:

Riboxin-Darnitsa is indicated for the treatment of various heart conditions, liver diseases, and neurological disorders.

Contraindications:

Do not use Riboxin-Darnitsa in case of hypersensitivity to inosine or any other component of the product.

Directions:

Follow the instructions provided by your healthcare provider. Do not exceed the recommended dosage.

Scientific Evidence:

Inosine, the active ingredient in Riboxin-Darnitsa, plays a crucial role in cellular energy metabolism. Research has shown that inosine supplementation can improve myocardial function and increase exercise tolerance in patients with heart failure. Additionally, inosine has been studied for its potential neuroprotective effects in conditions such as Parkinson’s disease and Alzheimer’s.

Additional Information:

Riboxin-Darnitsa is well-tolerated and has a good safety profile. It is commonly used as an adjuvant therapy in cardiovascular and neurological disorders. Consult your healthcare provider for personalized recommendations and dosage adjustments.

Studies have also suggested that inosine may have anti-inflammatory and antioxidant properties, further supporting its potential therapeutic benefits in various disease states. Clinical trials continue to explore the full scope of Riboxin-Darnitsa’s pharmacological effects and its role in improving patient outcomes.